Ligand validation:2I62

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 2I62 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2I62_SAH_B_4002	88%	26%	0.085	0.96	1.28	1.69	3	5	0	0	100%	1
2I62_SAH_C_4003	87%	24%	0.077	0.948	1.24	1.86	3	6	1	0	100%	1
2I62_SAH_D_4004	87%	27%	0.086	0.956	1.21	1.71	2	4	0	0	100%	1
2I62_SAH_A_4001	79%	24%	0.087	0.933	1.35	1.78	3	5	0	0	100%	1
5XVK_SAH_B_301	92%	30%	0.078	0.969	1.19	1.6	3	5	1	0	100%	1
5YJI_SAH_A_301	80%	29%	0.127	0.977	1.13	1.68	2	4	0	0	100%	0.916
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
2BB3_SAH_B_203	100%	9%	0.027	0.993	2.32	2.18	9	6	4	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1
6U8W_SAH_A_901	100%	22%	0.028	0.995	1.23	1.96	3	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.